Prestige Consumer Healthcare (PBH) Cash from Operations Growth (1y) (2011 - 2025)
Prestige Consumer Healthcare (PBH) Cash from Operations Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.00 Bn | 39.35 Bn | 2.15 Bn | 81.06% |
| 3 | Zoetis | 31.59 Bn | 29.92 Bn | 1.05 Bn | 8.26% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -46.22% |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 63.59% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 73.78% |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 33.73% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 16.88% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.43 Bn | 2.37 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20.27% |
| Sep 30, 2025 | -17.64% |
| Jun 30, 2025 | 44.25% |
| Mar 31, 2025 | -7.56% |
| Dec 31, 2024 | -8.93% |
| Sep 30, 2024 | 11.75% |
| Jun 30, 2024 | 13.91% |
| Mar 31, 2024 | 13.43% |
| Dec 31, 2023 | 30.09% |
| Sep 30, 2023 | 8.55% |
| Jun 30, 2023 | -17.44% |
| Mar 31, 2023 | -6.56% |
| Dec 31, 2022 | -17.13% |
| Sep 30, 2022 | -5.97% |
| Jun 30, 2022 | -15.96% |
| Mar 31, 2022 | 6.84% |
| Dec 31, 2021 | 34.68% |
| Sep 30, 2021 | 17.37% |
| Jun 30, 2021 | -7.78% |
| Mar 31, 2021 | 5.28% |